Suspension

Project Image

Therapeutic Indication

Gastroesophageal reflux disease (GERD)
Acid reflux & heartburn
Indigestion & dyspepsia
Pregnancy-related reflux (under medical advice)
Post-meal acidity
+91 85919 78885

SODIUM ALGINATE + SODIUM BICARBONATE + CALCIUM CARBONATE SUSPENSION

Suspension

This suspension is a combination of a raft-forming agent and antacids designed to provide fast and long-lasting relief from acid reflux. Sodium Alginate forms a protective gel-like “raft” that floats on the stomach contents, preventing acid from refluxing into the esophagus. Sodium Bicarbonate reacts with gastric acid to produce carbon dioxide, aiding raft formation and providing quick relief, while Calcium Carbonate neutralizes excess stomach acid.
The formulation provides dual action—mechanical barrier and acid neutralization—ensuring effective symptom control and protection of the esophageal lining.

Speciality Gastroenterology | Antacid | Anti-reflux
Tags Acidity Relief | GERD Care | Heartburn Relief
Strength
  • Sodium Alginate – 250 mg
  • Sodium Bicarbonate – 133.5 mg
  • Calcium Carbonate – 80 mg
Packing Size
  • 150 ml Bottle
  • 200 ml Bottle

Check all Tablet Range

Click to know More

Mechanism

Sodium Alginate
Forms a viscous gel (raft) that floats on gastric contents, preventing reflux of acid into the esophagus.
Sodium Bicarbonate
Reacts with gastric acid to release carbon dioxide, aiding raft formation and providing rapid acid neutralization.
Calcium Carbonate
Neutralizes gastric acid, increasing pH and reducing irritation of the stomach lining.

Side Effects

  • Bloating
  • Constipation or diarrhea
  • Nausea

Contraindication

  • Hypersensitivity to any component
  • Severe renal impairment
  • Hypercalcemia

Dosage

  • Adults and Children over 12 years: 10-20 ml
    Children (6 to 12 years): 5-10 ml
    after meals and at bedtime.
  • As directed by the physician.

DRUG INTERACTIONS

  • Do not use if allergic to any ingredient.
  • Care should be taken if on a highly restricted sodium diet and treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal calculi.
  • A time interval of 2 hours should be considered between Rasoraft intake and administration of other medicinal products.

Warning and Precautions

  • Shake well before use
  • Do not exceed recommended dose
  • Maintain a gap of 1–2 hours with other medications
  • Use cautiously in renal impairment or calcium disorders
  • Avoid prolonged use without medical advice
  • Store in a cool, dry place
  • Keep out of reach of children

Disclaimer

All product details on this website are for reference and informational purposes only and are not directed at patients or consumers.
As a contract manufacturer, DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all liability arising from reliance on this information.
Please consult a healthcare professional before using any medicinal product.